University of Chicago-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

    Journal of Clinical Oncology, Vol. 42, Núm. 24, pp. 2918-2927